Giuseppe Sabatino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Giuseppe Sabatino has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Verrotti
Department of Paediatrics, University of Chieti, Italy
11 shared publications F Chiarelli
8 shared publications- Pierluigi Antinolfi
Division of Orthopedics and Trauma Surgery, S. Maria della Misericordia Hospital, Perugia, Italy
7 shared publications A Caraffa
5 shared publicationsE Toniato
5 shared publications- Vincenzo Salini
Vita-Salute San Raffaele University, Milan, Italy
5 shared publications
Latest Publications
- 16 March 2013
- Vol. 27 (1) , 1-7
Comparison of beneficial actions of non-steroidal anti-inflammatory drugs to flavonoids.
Inflammation is involved in increasing number of diseases necessitating the development of new, effective and safe treatments. Non steroidal anti-inflammatory drugs (NSAIDs) have been helpful in many instances, but they only inhibit cyclooxygenase (COX), but not the generation or actions of cytokines. Instead, some natural flavonoids have multiple anti-inflammatory effects, including COX inhibition, and a much safer profile. Increasing evidence indicates that inflammation plays a critical role in the pathogenesis of many diseases that also involve mast cells. Consequently, the need for new, effective and safe anti-inflammatory drugs is all the more urgent. Corticosteroids are quite potent, but have many adverse effects such as increased risk of infections, osteoporosis, glaucoma and depression. Biological agents such anti-TNF are useful in certain conditions, such as rheumatoid arthritis and psoriasis, but has been associated with increased risk of infection and leukemia.
- 16 March 2013
- Vol. 27 (1) , 1-7
Comparison of beneficial actions of non-steroidal anti-inflammatory drugs to flavonoids.
Inflammation is involved in increasing number of diseases necessitating the development of new, effective and safe treatments. Non steroidal anti-inflammatory drugs (NSAIDs) have been helpful in many instances, but they only inhibit cyclooxygenase (COX), but not the generation or actions of cytokines. Instead, some natural flavonoids have multiple anti-inflammatory effects, including COX inhibition, and a much safer profile. Increasing evidence indicates that inflammation plays a critical role in the pathogenesis of many diseases that also involve mast cells. Consequently, the need for new, effective and safe anti-inflammatory drugs is all the more urgent. Corticosteroids are quite potent, but have many adverse effects such as increased risk of infections, osteoporosis, glaucoma and depression. Biological agents such anti-TNF are useful in certain conditions, such as rheumatoid arthritis and psoriasis, but has been associated with increased risk of infection and leukemia.
- 18 December 2012
- Vol. 26 (4) , 577-86
Impact of IL -9 and IL-33 in mast cells.
Cytokines serve as chemical communicators from one cell to another and most of them have pro-inflammatory activity. Mast cells have been recognised as important mediators of the pathogenesis of allergy and inflammation, suggesting a role for IL-33-mediated mast cell activation. IL-33 was recently identified as a ligand for the orphan IL-1 family receptor T1/ST2 and is mainly expressed by mast cells, fibroblasts, epithelial cells, and endothelial cells, particularly in high endothelial venules. IL-33 is a potent inducer of pro-inflammatory cytokines such as IL-1, IL-6, IL-13 and TNF, and chemokines (MCP-1), by mast cells. Substance P is capable to induce VEGF from mast cells, and IL-33, the newest pro-inflammatory member of the IL-1 cytokine family, augments the effect of SP in VEGF transcription and translation protein. IL-9 is a pleiotropic and is expressed by multiple T helper (TH) cell subsets. IL-9 promotes the expression of mast cell pro-inflammatory cytokines in vitro and is involved in Th2 responses. This article focuses on recent developments of mast cells, IL-9 and IL-33, and recent literature and investigations were reviewed.
- 18 December 2012
- Vol. 26 (4) , 577-86
Impact of IL -9 and IL-33 in mast cells.
Cytokines serve as chemical communicators from one cell to another and most of them have pro-inflammatory activity. Mast cells have been recognised as important mediators of the pathogenesis of allergy and inflammation, suggesting a role for IL-33-mediated mast cell activation. IL-33 was recently identified as a ligand for the orphan IL-1 family receptor T1/ST2 and is mainly expressed by mast cells, fibroblasts, epithelial cells, and endothelial cells, particularly in high endothelial venules. IL-33 is a potent inducer of pro-inflammatory cytokines such as IL-1, IL-6, IL-13 and TNF, and chemokines (MCP-1), by mast cells. Substance P is capable to induce VEGF from mast cells, and IL-33, the newest pro-inflammatory member of the IL-1 cytokine family, augments the effect of SP in VEGF transcription and translation protein. IL-9 is a pleiotropic and is expressed by multiple T helper (TH) cell subsets. IL-9 promotes the expression of mast cell pro-inflammatory cytokines in vitro and is involved in Th2 responses. This article focuses on recent developments of mast cells, IL-9 and IL-33, and recent literature and investigations were reviewed.
- 22 December 2011
- Published by Georg Thieme Verlag KG in Ultraschall in der Medizin - European Journal of Ultrasound
- Vol. 32 (S 02) , E129-E133
Bone Maturity and Thyroidal Status at Birth: Role of the Ultrasonographic Evaluation of the Distal Femoral Epiphysis
Purpose: Thyroidal hormones are important for bone development, and ultrasonographic (US) evaluation of the distal femoral epiphysis (DFE) has recently been suggested as a new method for the assessment of skeletal maturity in infants. A delayed bone maturation, expressed by a smaller or absent DFE nucleus (in terms of DFE surface area, sum of the epiphyseal diameters, or DFE height and acetabular size), has been largely demonstrated in diagnosed hypothyroid infants, while no data analyze the role and meaning of the DFE dimensions (in terms of volume) in newborn before knowledge of the congenital neonatal screening results. The aims of the present study were to ultrasonographically evaluate the volume of DFE in newborns, and to determine whether it has any predictive role for the thyroidal status at birth. Materials and Methods: 238 newborns (M/F: 121 /117) were evaluated. The gestational age, body weight and length at birth were registered. Neonatal screening for congenital hypothyroidism (CH), based on TSH levels on blood spot, was performed in all on the 3 rd day of life. The DFE volume was ultrasonographically evaluated, taking into account the three diameters of the DFE nucleus, within 48 hours of birth. Results: No newborn was found to have CH on neonatal screening. The DFE volume ranged between 0.00 cm and 0.61 cm (mean 0.14 ± 0.10 cm, median 0.13 cm). The DFE volume did not differ between males and females, while it was significantly greater in at term babies than in preterm babies. No differences in TSH values at screening were noted among the groups. The DFE volume was significantly related to gestational age, birth weight and length. A significant relationship was found between the DFE volume and TSH concentrations at screening. Conclusion: US evaluation of DFE volume provides a simple method for assessing bone maturity at birth, which is related to gestational age, body weight and length at birth. Nonetheless, it has any predictive role for thyroidal status at birth, being not related to TSH levels on neonatal screening for CH. Ziel: Die Schilddrüsenhormone sind wichtig für die Knochenentwicklung und die ultrasonografische (US) Bewertung der distalen femoralen Epiphyse (DFE) wurde vor Kurzem als Methode zur Bestimmung der skelettalen Reife bei Kindern empfohlen. Eine verzögerte Knochenreifung, ausgedrückt durch einen niedrigeren oder fehlenden DFE-Nukleus (in Bezug auf die Oberfläche, die Summe der Epiphysen-Durchmesser, der DFE-Höhe und der azetabulären Größe), wurde zum großen Teil bei Kindern mit Hypothyreose gezeigt, während es keine Daten über die Rolle und Bedeutung der DFE-Maße (in Bezug auf das Volumen) im Neugeborenen vor Kenntnis der Ergebnisse des konnatalen Neugeborenenscreenings gibt. Die Ziele dieser Studie bestehen in der ultrasonografischen Bewertung des DFE-Volumens bei Neugeborenen und der Ermittlung dessen prädiktiven Wertes für den Schilddrüsenstatus bei Geburt. Material und Methoden: 238 Neugeborene (M/W: 121 /117) wurden untersucht. Das Gestationsalter, das Körpergewicht und die Länge bei Geburt wurden festgehalten. Bei allen wurde am dritten Lebenstag ein Neugeborenenscreening auf konnatale Hypothyreose (CH) basierend auf den TSH-Spiegeln im getrockneten Fersenblut durchgeführt. Innerhalb von 48 Stunden nach Geburt wurde das DFE-Volumen sonografisch bewertet, unter Berücksichtigung der drei Durchmesser des DFE-Nukleus. Ergebnisse: Bei keinem der Neugeborenen wurde beim neonatalen Screening eine CH entdeckt. Das DFE-Volumen war in einem Bereich zwischen 0,00 und 0,61 cm (Mittelwert 0,14 ± 0,10 cm, Median 0,13 cm). Das DFE-Volumen zeigte keine Unterschiede zwischen Jungen und Mädchen, während es bei Reifgeborenen signifikant höher war als bei Frühgeborenen. Beim Screening wurde zwischen den Gruppen kein Unterschiede in den TSH-Spiegeln bemerkt. Das DFE-Volumen zeigte einen signifikant Zusammenhang mit Gestationsalter, Geburtsgewicht und -länge. Ein signifikanter Zusammenhang zwischen DFE-Volumen und TSH-Konzentrationen beim Screening wurde gefunden. Schlussfolgerung: Die US-Bewertung des DFE-Volumens stellt eine einfache Methode zur Bestimmung der Knochenreife bei Geburt dar, die in Beziehung zu Gestationsalter, Körpergewicht und Länge bei Geburt steht. Trotzdem sie keinen Bezug zu den TSH-Spiegeln beim Neugeborenenscreening auf CH hat, hat sie einen gewissen prädiktiven Wert für den Schilddrüsenstatus bei Geburt.
- 22 December 2011
- Published by Georg Thieme Verlag KG in Ultraschall in der Medizin - European Journal of Ultrasound
- Vol. 32 (S 02) , E129-E133
Bone Maturity and Thyroidal Status at Birth: Role of the Ultrasonographic Evaluation of the Distal Femoral Epiphysis
Purpose: Thyroidal hormones are important for bone development, and ultrasonographic (US) evaluation of the distal femoral epiphysis (DFE) has recently been suggested as a new method for the assessment of skeletal maturity in infants. A delayed bone maturation, expressed by a smaller or absent DFE nucleus (in terms of DFE surface area, sum of the epiphyseal diameters, or DFE height and acetabular size), has been largely demonstrated in diagnosed hypothyroid infants, while no data analyze the role and meaning of the DFE dimensions (in terms of volume) in newborn before knowledge of the congenital neonatal screening results. The aims of the present study were to ultrasonographically evaluate the volume of DFE in newborns, and to determine whether it has any predictive role for the thyroidal status at birth. Materials and Methods: 238 newborns (M/F: 121 /117) were evaluated. The gestational age, body weight and length at birth were registered. Neonatal screening for congenital hypothyroidism (CH), based on TSH levels on blood spot, was performed in all on the 3 rd day of life. The DFE volume was ultrasonographically evaluated, taking into account the three diameters of the DFE nucleus, within 48 hours of birth. Results: No newborn was found to have CH on neonatal screening. The DFE volume ranged between 0.00 cm and 0.61 cm (mean 0.14 ± 0.10 cm, median 0.13 cm). The DFE volume did not differ between males and females, while it was significantly greater in at term babies than in preterm babies. No differences in TSH values at screening were noted among the groups. The DFE volume was significantly related to gestational age, birth weight and length. A significant relationship was found between the DFE volume and TSH concentrations at screening. Conclusion: US evaluation of DFE volume provides a simple method for assessing bone maturity at birth, which is related to gestational age, body weight and length at birth. Nonetheless, it has any predictive role for thyroidal status at birth, being not related to TSH levels on neonatal screening for CH. Ziel: Die Schilddrüsenhormone sind wichtig für die Knochenentwicklung und die ultrasonografische (US) Bewertung der distalen femoralen Epiphyse (DFE) wurde vor Kurzem als Methode zur Bestimmung der skelettalen Reife bei Kindern empfohlen. Eine verzögerte Knochenreifung, ausgedrückt durch einen niedrigeren oder fehlenden DFE-Nukleus (in Bezug auf die Oberfläche, die Summe der Epiphysen-Durchmesser, der DFE-Höhe und der azetabulären Größe), wurde zum großen Teil bei Kindern mit Hypothyreose gezeigt, während es keine Daten über die Rolle und Bedeutung der DFE-Maße (in Bezug auf das Volumen) im Neugeborenen vor Kenntnis der Ergebnisse des konnatalen Neugeborenenscreenings gibt. Die Ziele dieser Studie bestehen in der ultrasonografischen Bewertung des DFE-Volumens bei Neugeborenen und der Ermittlung dessen prädiktiven Wertes für den Schilddrüsenstatus bei Geburt. Material und Methoden: 238 Neugeborene (M/W: 121 /117) wurden untersucht. Das Gestationsalter, das Körpergewicht und die Länge bei Geburt wurden festgehalten. Bei allen wurde am dritten Lebenstag ein Neugeborenenscreening auf konnatale Hypothyreose (CH) basierend auf den TSH-Spiegeln im getrockneten Fersenblut durchgeführt. Innerhalb von 48 Stunden nach Geburt wurde das DFE-Volumen sonografisch bewertet, unter Berücksichtigung der drei Durchmesser des DFE-Nukleus. Ergebnisse: Bei keinem der Neugeborenen wurde beim neonatalen Screening eine CH entdeckt. Das DFE-Volumen war in einem Bereich zwischen 0,00 und 0,61 cm (Mittelwert 0,14 ± 0,10 cm, Median 0,13 cm). Das DFE-Volumen zeigte keine Unterschiede zwischen Jungen und Mädchen, während es bei Reifgeborenen signifikant höher war als bei Frühgeborenen. Beim Screening wurde zwischen den Gruppen kein Unterschiede in den TSH-Spiegeln bemerkt. Das DFE-Volumen zeigte einen signifikant Zusammenhang mit Gestationsalter, Geburtsgewicht und -länge. Ein signifikanter Zusammenhang zwischen DFE-Volumen und TSH-Konzentrationen beim Screening wurde gefunden. Schlussfolgerung: Die US-Bewertung des DFE-Volumens stellt eine einfache Methode zur Bestimmung der Knochenreife bei Geburt dar, die in Beziehung zu Gestationsalter, Körpergewicht und Länge bei Geburt steht. Trotzdem sie keinen Bezug zu den TSH-Spiegeln beim Neugeborenenscreening auf CH hat, hat sie einen gewissen prädiktiven Wert für den Schilddrüsenstatus bei Geburt.
- 9 March 2011
- Vol. 25 (1) , 7-11
Impact of IL-18 on inflammation.
IL-18 is produced by many cell types, such as Kupffer cells, keratinocytes, macrophages, dendritic cells, and activated T cells stimulated by LPS. It is an important regulator of both innate and acquired immune responses. IL-18 plays a central role in rheumatoid arthritis since the T cells and macrophages that invade the synovial. These finding support a role for IL-18 in inflammation, allergy and immune diseases.
- 9 March 2011
- Vol. 25 (1) , 7-11
Impact of IL-18 on inflammation.
IL-18 is produced by many cell types, such as Kupffer cells, keratinocytes, macrophages, dendritic cells, and activated T cells stimulated by LPS. It is an important regulator of both innate and acquired immune responses. IL-18 plays a central role in rheumatoid arthritis since the T cells and macrophages that invade the synovial. These finding support a role for IL-18 in inflammation, allergy and immune diseases.
- 3 December 2010
- Vol. 24 (4) , 385-90
Interrelationship between vitamins and cytokines in immunity.
Cytokines are important proteins that modulate immunity and inflammation. Vitamins are also involved in immunity and inflammation. They are found to restore the ability of some cells to produce certain cytokines. Vitamin deficiency appears to affect the mechanism of immune cells, though the impact of reduced cytokine response in vitamin malnutrition is not clear. Vitamin D is involved in many medical conditions, such as infections and inflammation, and mediates innate immunity. Deficiency of vitamin D increases the risk of infectious and inflammatory diseases. In addition, this vitamin modulates Treg function and IL-10 production which is important for therapeutic treatment. Vitamin A increases inflammatory response and is involved in tissue damage; moreover, vitamin A is a key modulator of TGFbeta which can suppress several cytokines. Vitamin E, an anti-ageing compound, is associated with a defect of naive T cells and may inhibit some inflammatory compounds such as prostaglandin generation.
- 3 December 2010
- Vol. 24 (4) , 385-90
Interrelationship between vitamins and cytokines in immunity.
Cytokines are important proteins that modulate immunity and inflammation. Vitamins are also involved in immunity and inflammation. They are found to restore the ability of some cells to produce certain cytokines. Vitamin deficiency appears to affect the mechanism of immune cells, though the impact of reduced cytokine response in vitamin malnutrition is not clear. Vitamin D is involved in many medical conditions, such as infections and inflammation, and mediates innate immunity. Deficiency of vitamin D increases the risk of infectious and inflammatory diseases. In addition, this vitamin modulates Treg function and IL-10 production which is important for therapeutic treatment. Vitamin A increases inflammatory response and is involved in tissue damage; moreover, vitamin A is a key modulator of TGFbeta which can suppress several cytokines. Vitamin E, an anti-ageing compound, is associated with a defect of naive T cells and may inhibit some inflammatory compounds such as prostaglandin generation.
- Open Access
- 1 January 2010
- Published by Springer Nature in Proteome Science
- Vol. 8 (1) , 18
Proteome analysis of human Wharton's jelly cells during in vitro expansion
The human umbilical cord contains mucoid connective tissue and fibroblast-like cells. These cells named Wharton's jelly cells, (WJCs) display properties similar to mesenchymal stem cells therefore representing a rich source of primitive cells to be potentially used in regenerative medicine. To better understand their self-renewal and potential in vitro expansion capacity, a reference 2D map was constructed as a proteomic data set. 158 unique proteins were identified. More than 30% of these proteins belong to cytoskeleton compartment. We also found that several proteins including Shootin1, Adenylate kinase 5 isoenzyme and Plasminogen activator-inhibitor 2 are no longer expressed after the 2nd passage of in vitro replication. This indicates that the proliferative potency of these cells is reduced after the initial stage of in vitro growing. At the end of cellular culturing, new synthesized proteins, including, ERO1-like protein alpha, Aspartyl-tRNA synthetase and Prolyl-4-hydroxylase were identified. It is suggested that these new synthesized proteins are involved in the impairment of cellular surviving during replication and differentiation time. Our work represents an essential step towards gaining knowledge of the molecular properties of WJCs so as to better understand their possible use in the field of cell therapy and regenerative medicine.
- 1 January 2010
- Published by Springer Nature in Proteome Science
- Vol. 8 (1) , 18
Open AccessProteome analysis of human Wharton's jelly cells during in vitro expansion
The human umbilical cord contains mucoid connective tissue and fibroblast-like cells. These cells named Wharton's jelly cells, (WJCs) display properties similar to mesenchymal stem cells therefore representing a rich source of primitive cells to be potentially used in regenerative medicine. To better understand their self-renewal and potential in vitro expansion capacity, a reference 2D map was constructed as a proteomic data set. 158 unique proteins were identified. More than 30% of these proteins belong to cytoskeleton compartment. We also found that several proteins including Shootin1, Adenylate kinase 5 isoenzyme and Plasminogen activator-inhibitor 2 are no longer expressed after the 2nd passage of in vitro replication. This indicates that the proliferative potency of these cells is reduced after the initial stage of in vitro growing. At the end of cellular culturing, new synthesized proteins, including, ERO1-like protein alpha, Aspartyl-tRNA synthetase and Prolyl-4-hydroxylase were identified. It is suggested that these new synthesized proteins are involved in the impairment of cellular surviving during replication and differentiation time. Our work represents an essential step towards gaining knowledge of the molecular properties of WJCs so as to better understand their possible use in the field of cell therapy and regenerative medicine.
- 17 December 2009
- Vol. 23 (4) , 231-8
Infections and mast cells.
Mast cells play a role in various physiological functions: innate and acquired immunity, epithelium remodelling and proliferation, angiogenesis, cancer, inflammation and infections. Mast cells are activated by cross-linking of FcERI molecules, which are involved in the binding of multivalent antigens to the attached IgE molecules, resulting in a variety of responses including the immediate release of potent inflammatory mediators. In addition, mast cell biology consists in the capability to secrete preformed mediators which include biogenic amines and newly synthetized mediators, which include lipid-derived mediators and cytokines. It has been reported that parasite infections induce a systemic immunomodulatory network, including regulatory T cells, pro-inflammatory and anti-inflammatory cytokines, which might play a key role in the allergic phenotype. Here, in this article, we revisited the relationship between mast cells and infections.
- 17 December 2009
- Vol. 23 (4) , 231-8
Infections and mast cells.
Mast cells play a role in various physiological functions: innate and acquired immunity, epithelium remodelling and proliferation, angiogenesis, cancer, inflammation and infections. Mast cells are activated by cross-linking of FcERI molecules, which are involved in the binding of multivalent antigens to the attached IgE molecules, resulting in a variety of responses including the immediate release of potent inflammatory mediators. In addition, mast cell biology consists in the capability to secrete preformed mediators which include biogenic amines and newly synthetized mediators, which include lipid-derived mediators and cytokines. It has been reported that parasite infections induce a systemic immunomodulatory network, including regulatory T cells, pro-inflammatory and anti-inflammatory cytokines, which might play a key role in the allergic phenotype. Here, in this article, we revisited the relationship between mast cells and infections.
- 10 October 2008
- Vol. 22 (3) , 145-51
Mast cells and chemokines.
Chemokines are small proteins (8-12 kD polypeptides) secreted by the cells of innate and adaptive immunity that mediate many of the functions of these cells, including recruitment of other cells. They are classified into families: CC, CXC and CX3C. CXC chemoattract mainly on neutrophils and CC act mainly on monocytes, eosinophils and mast cells. Mast cells are important cells in the modulation of allergic and inflammatory diseases. Activation of mast cells with specific IgE antibody and antigens or other active compounds such as Substance P and corticotrophin releasing hormone causes transcription and translation of several different cytokines/chemokines such as tumor necrosis factor-alpha (TNF-alpha), macrophage inflammatory protein-1 (MIP-1) and GM-CSF, RANTES, MCP-1, CXCL8, along with other proinflammatory compounds, proteases (chymase and tryptase), histamine, leukotrienes and prostaglandin D2. Neutralization of chemokines may reduce inflammatory cell accumulation and may protect against allergy, toxic shock syndrome and inflammatory diseases.
- 10 October 2008
- Vol. 22 (3) , 145-51
Mast cells and chemokines.
Chemokines are small proteins (8-12 kD polypeptides) secreted by the cells of innate and adaptive immunity that mediate many of the functions of these cells, including recruitment of other cells. They are classified into families: CC, CXC and CX3C. CXC chemoattract mainly on neutrophils and CC act mainly on monocytes, eosinophils and mast cells. Mast cells are important cells in the modulation of allergic and inflammatory diseases. Activation of mast cells with specific IgE antibody and antigens or other active compounds such as Substance P and corticotrophin releasing hormone causes transcription and translation of several different cytokines/chemokines such as tumor necrosis factor-alpha (TNF-alpha), macrophage inflammatory protein-1 (MIP-1) and GM-CSF, RANTES, MCP-1, CXCL8, along with other proinflammatory compounds, proteases (chymase and tryptase), histamine, leukotrienes and prostaglandin D2. Neutralization of chemokines may reduce inflammatory cell accumulation and may protect against allergy, toxic shock syndrome and inflammatory diseases.
- 4 July 2008
- Vol. 22 (2) , 93-8
Impact of substance P on cellular immunity.
Much evidence suggests a cross-talking between nerve fibers and the immunity system. The immunomodulation by substance P includes cell activation and proliferation of human cells, with cytokine and chemokine generation and release. Substance P was first isolated by Leeman et al. as an undecapeptide with important neurotransmitter-neuromodulator effects. In addition, substance P was shown to induce and mediate inflammation, angiogenesis, infections, intestinal mucosal immunity and stress. Substance P is able to activate several immune cells, such as CD4+ and CD8+ T lymphocytes, mast cells, NK cells and macrophages. In recent studies we have shown that substance P can activate interleukin-8, a CXC chemokine, demonstrating its involvement in immune cell chemoattraction. We believe that substance P is important in understanding the pathophysiology of inflammation.
- 4 July 2008
- Vol. 22 (2) , 93-8
Impact of substance P on cellular immunity.
Much evidence suggests a cross-talking between nerve fibers and the immunity system. The immunomodulation by substance P includes cell activation and proliferation of human cells, with cytokine and chemokine generation and release. Substance P was first isolated by Leeman et al. as an undecapeptide with important neurotransmitter-neuromodulator effects. In addition, substance P was shown to induce and mediate inflammation, angiogenesis, infections, intestinal mucosal immunity and stress. Substance P is able to activate several immune cells, such as CD4+ and CD8+ T lymphocytes, mast cells, NK cells and macrophages. In recent studies we have shown that substance P can activate interleukin-8, a CXC chemokine, demonstrating its involvement in immune cell chemoattraction. We believe that substance P is important in understanding the pathophysiology of inflammation.
- Open Access
- 1 May 2008
- Published by SAGE Publications in European Journal of Inflammation
- Vol. 6 (2) , 59-64
Substance P: An Inflammatory Peptide
Substance P (SP) is involved in neurogenic inflammation and in the pathogenesis of several inflammatory diseases, demonstrating that there is a narrow interrelationship between the nervous system and immunity. Macrophage functions are altered in stress, therefore, since SP is a macrophage activator, its biological effect has been intimately linked to stress. In fact, SP enhances LPS-induced macrophage TNFα production from stressed animals and stimulates the production of IL-8 CXC chemokine response in a mast cell line in vitro. The stress-induced cytokines from macrophage also alter and contribute to inflammation. Understanding the pathophysiology of inflammation and the role of the chemical mediator SP may improve inflammation management.
- 1 May 2008
- Published by SAGE Publications in European Journal of Inflammation
- Vol. 6 (2) , 59-64
Open AccessSubstance P: An Inflammatory Peptide
Substance P (SP) is involved in neurogenic inflammation and in the pathogenesis of several inflammatory diseases, demonstrating that there is a narrow interrelationship between the nervous system and immunity. Macrophage functions are altered in stress, therefore, since SP is a macrophage activator, its biological effect has been intimately linked to stress. In fact, SP enhances LPS-induced macrophage TNFα production from stressed animals and stimulates the production of IL-8 CXC chemokine response in a mast cell line in vitro. The stress-induced cytokines from macrophage also alter and contribute to inflammation. Understanding the pathophysiology of inflammation and the role of the chemical mediator SP may improve inflammation management.